Home > Insider Trading > Filing (0001587221-17-000020)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1587221	Zosano Pharma Corp	ZSAN	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1213529	Peter John Walker	C/O Zosano Pharma Corporation 34790 Ardentech Court Fremont CA 94555	Interim Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-24	36,166	$1.34	169,344	No	4	P	Direct
Common Stock	Acquisiton	2017-05-25	37,550	$1.37	206,894	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
This Amended Form 4 is being filed to revise Footnotes 1 and 2 of the original Form 4 to state that the shares were "purchased" and not "sold." This amendment corrects an administrative error.